Published in Clinical Oncology Week, September 15th, 2008
The Evident(TM) microwave ablation system received 510(k) clearance from the United States Food and Drug Administration for use in soft tissue, and is now the first microwave ablation system available globally.
The Evident(TM) microwave ablation system is intended for coagulation of soft tissue during percutaneous, laparoscopic and open surgical procedures. Microwave energy emanates from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.